Page 14 - Read Online
P. 14

Cox et al. J Cancer Metastasis Treat 2021;7:25  https://dx.doi.org/10.20517/2394-4722.2021.55  Page 9 of 11

               DECLARATIONS
               Authors’ contributions
               Performed the literature search and drafted and revised the manuscript: Cox MC, van den Bosch S
               Critically reviewed and edited the manuscript: van den Bosch S, Dijkema T, Kaanders JHAM
               Supervised the writing process: Kaanders JHAM
               Approved the final version of the report: Cox MC, van den Bosch S, Dijkema T, Kaanders JHAM


               Availability of data and materials
               Not applicable.


               Financial support and sponsorship
               None.


               Conflict of interest
               All authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               Not applicable.

               Consent for publication
               Not applicable.

               Copyright
               © The Author(s) 2021.


               REFERENCES
               1.       Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced
                   head and neck cancer. N Engl J Med 1998;338:1798-804.  DOI  PubMed
               2.       Pignon JP, le Maître A, Maillard E, Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93
                   randomised trials and 17,346 patients. Radiother Oncol 2009;92:4-14.  DOI  PubMed
               3.       Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal
                   cancer. N Engl J Med 2003;349:2091-8.  DOI  PubMed
               4.       Maccomb WS, Fletcher GH. Planned combination of surgery and radiation in treatment of advanced primary head and neck cancers.
                   Am J Roentgenol Radium Ther Nucl Med 1957;77:397-414.  PubMed
               5.       den Brekel MW. Lymph node metastases: CT and MRI. Eur J Radiol 2000;33:230-8.  DOI  PubMed
               6.       de Bondt RB, Nelemans PJ, Bakers F, et al. Morphological MRI criteria improve the detection of lymph node metastases in head and
                   neck squamous cell carcinoma: multivariate logistic regression analysis of MRI features of cervical lymph nodes. Eur Radiol
                   2009;19:626-33.  DOI  PubMed  PMC
               7.       Takes RP, Knegt P, Manni JJ, et al. Regional metastasis in head and neck squamous cell carcinoma: revised value of US with US-
                   guided FNAB. Radiology 1996;198:819-23.  DOI  PubMed
               8.       de Bondt RB, Nelemans PJ, Hofman PA, et al. Detection of lymph node metastases in head and neck cancer: a meta-analysis
                   comparing US, USgFNAC, CT and MR imaging. Eur J Radiol 2007;64:266-72.  DOI  PubMed
               9.       Zhou SM, Wong TZ, Marks LB. Using FDG-PET activity as a surrogate for tumor cell density and its effect on equivalent uniform
                   dose calculation. Med Phys 2004;31:2577-83.  DOI  PubMed
               10.      Kim SJ, Pak K, Kim K. Diagnostic accuracy of F-18 FDG PET or PET/CT for detection of lymph node metastasis in clinically node
                   negative head and neck cancer patients; A systematic review and meta-analysis. Am J Otolaryngol 2019;40:297-305.  DOI  PubMed
               11.      Sun R, Tang X, Yang Y, Zhang C. (18)FDG-PET/CT for the detection of regional nodal metastasis in patients with head and neck
                   cancer: a meta-analysis. Oral Oncol 2015;51:314-20.  DOI  PubMed
               12.      Yongkui L, Jian L, Wanghan, Jingui L. 18FDG-PET/CT for the detection of regional nodal metastasis in patients with primary head
                   and neck cancer before treatment: a meta-analysis. Surg Oncol 2013;22:e11-6.  DOI  PubMed
                                                               18
               13.      Lowe VJ, Duan F, Subramaniam RM, et al. Multicenter trial of [ F]fluorodeoxyglucose positron emission tomography/computed
                   tomography staging of head and neck cancer and negative predictive value and surgical impact in the N0 neck: results from ACRIN
                   6685. J Clin Oncol 2019;37:1704-12.  DOI  PubMed  PMC
               14.      Roh JL, Park JP, Kim JS, et al. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck
                   palpation findings: a prospective study. Radiology 2014;271:153-61.  DOI  PubMed
               15.      Yamazaki Y, Saitoh M, Notani K, et al. Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck
                   cancer. Ann Nucl Med 2008;22:177-84.  DOI  PubMed
               16.      Yoon DY, Hwang HS, Chang SK, et al. CT, MR, US,18F-FDG PET/CT, and their combined use for the assessment of cervical lymph
                   node metastases in squamous cell carcinoma of the head and neck. Eur Radiol 2009;19:634-42.  DOI  PubMed
   9   10   11   12   13   14   15   16   17   18   19